Evommune raises $125M privately
Source: SeekingAlpha
2026-02-13 02:06:32 ET
More on Evommune, Inc.
- Evommune's EVO301 Phase 2a Data Drives 70% Stock Surge
- Evommune surges on mid-stage trial win for eczema therapy
- Seeking Alpha’s Quant Rating on Evommune, Inc.
- Historical earnings data for Evommune, Inc.
- Financial information for Evommune, Inc.
Read the full article on Seeking Alpha
For further details see:
Evommune raises $125M privately
Evommune Inc.
NASDAQ: EVMN
EVMN Trading
-1.71% G/L:
$25.87 Last:
180,160 Volume:
$27.01 Open:
EVMN Latest News
EVMN Stock Data
$915,144,420
15,720,750
0.25%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Palo Alto
